LYELL IMMUNOPHARMA INC (LYEL) Earnings History & Surprises
NASDAQ:LYEL • US55083R2031
25.63 USD
+0.13 (+0.51%)
Last: Mar 10, 2026, 08:00 PM
Past quarterly earnings results for LYELL IMMUNOPHARMA INC (LYEL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 11, 2026
PeriodQ4 / 2025
EPS Estimate-$2.28
Revenue Estimate12.444K
Last Reported
Release DateMar 9, 2026
PeriodQ3 / 2025
EPS Reported-$2.13
EPS Surprise 20.98%
Revenue Surprise %
Beat Rate
38%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -2.13 | -2.70 | 20.98% | 37.35% | 15K | - | -55.88% | |
| Q2 2025 | -2.89 | -3.65 | 20.93% | 19.72% | 8K | - | -38.46% | |
| Q1 2025 | -3.54 | -3.67 | 3.59% | 26.25% | 7K | - | 133.33% | |
| Q4 2024 | -4.00 | -3.47 | -15.34% | - | 11K | - | -15.38% | |
| Q3 2024 | -3.40 | -4.08 | 16.67% | - | 34K | - | 36.00% | |
| Q2 2024 | -3.60 | -4.18 | 13.92% | - | 13K | - | -51.85% | |
| Q1 2024 | -4.80 | -4.28 | -12.04% | -4.35% | 3K | - | -95.38% | |
| Q4 2023 | -4.00 | -4.65 | 14.00% | -400.00% | 13K | - | -99.97% | |
| Q3 2023 | -3.40 | -5.10 | 33.33% | 39.29% | 25K | - | - | |
| Q2 2023 | -3.60 | -5.58 | 35.44% | -20.00% | 27K | - | -99.92% | |
| Q1 2023 | -4.60 | -5.78 | 20.41% | 17.86% | 65K | - | -88.18% | |
| Q4 2022 | -0.80 | -6.19 | 87.07% | 88.57% | 48.39M | 1.904M | 2,441.49% | 1,615.96% |
| Q3 2022 | -5.60 | -6.32 | 11.45% | -40.00% | 1.836M | -100.00% | -100.00% | |
| Q2 2022 | -3.00 | -6.32 | 52.56% | 83.15% | 35.74M | 1.088M | 3,184.93% | 1,258.94% |
| Q1 2022 | -5.60 | -5.85 | 4.24% | - | 550K | 1.02M | -46.08% | -77.55% |
| Q4 2021 | -7.00 | -5.61 | -24.78% | - | 2.82M | 2.907M | -2.99% | 22.08% |
| Q3 2021 | -4.00 | -5.51 | 27.38% | - | 2.76M | 2.346M | 17.65% | 157.94% |
| Q2 2021 | -17.80 | -7.45 | -139.05% | - | 2.63M | 2.295M | 14.60% | -15.71% |
| Q1 2021 | - | - | 2.45M | - | 94.44% | |||
| Q4 2020 | - | - | 2.31M | - | - | |||
| Q3 2020 | - | - | 1.07M | - | - | |||
| Q2 2020 | - | - | 3.12M | - | - | |||
| Q1 2020 | - | - | 1.26M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
7.54%
Max EPS beat (4)
20.98%
Min EPS beat (4)
-15.34%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, LYEL has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, LYEL has beaten the EPS estimates by 7.5% on average.
LYELL IMMUNOPHARMA INC / LYEL Earnings FAQ
When did LYELL IMMUNOPHARMA INC (LYEL) report earnings last quarter?
LYELL IMMUNOPHARMA INC (LYEL) last reported earnings on 3/9/2026.
Did LYEL stock beat earnings estimates in the most recent quarter?
LYELL IMMUNOPHARMA INC (LYEL) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does LYEL stock beat earnings estimates?
In the last 4 quarters, LYELL IMMUNOPHARMA INC (LYEL) has beaten EPS estimates in 3 out of 4 releases.